Response to: "rare serious complications of erlotinib therapy"

Acta Neurochir (Wien). 2013 Apr;155(4):745. doi: 10.1007/s00701-012-1603-y. Epub 2012 Dec 29.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Angiogenesis Inhibitors / administration & dosage*
  • Antibodies, Monoclonal, Humanized / administration & dosage*
  • Brain Neoplasms / drug therapy*
  • Female
  • Glioblastoma / drug therapy*
  • Humans
  • Male
  • Protein Kinase Inhibitors / administration & dosage*
  • Quinazolines / administration & dosage*

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal, Humanized
  • Protein Kinase Inhibitors
  • Quinazolines